Existing BPA - 1. 7900 ICP-MS and 1. Agilent 1290 Infinity III UPLC
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract involves the procurement of two advanced analytical instruments for the Food and Drug Administration: an Agilent 1290 Infinity III Ultra Performance Liquid Chromatography (UPLC) system and a 7900 Inductively Coupled Plasma Mass Spectrometry (ICP-MS) unit. These instruments are intended to replace older models that are frequently in disrepair and unable to sustain continuous operation. The UPLC will be used specifically for detecting prohibited or undeclared food additives in regulatory samples, while the ICP-MS will focus on testing for toxic metals in similar samples. This procurement supports the FDA’s regulatory testing capabilities by ensuring more reliable, efficient, and advanced technology is available for food safety analysis. The contract is classified under NAICS code 334516 and was announced as a forecast opportunity on March 11, 2026. Key points of contact include an acquisition liaison, with the contracting officer yet to be designated. The acquisition aligns with the FDA’s goal of maintaining cutting-edge instrumentation for critical public health monitoring activities related to food safety.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
